Clinical Trials Insight: 700054578

Trial Profile

Clinical Trials Insight: 700054578

Phase of Trial: Phase I

Latest Information Update: 15 Mar 2010

At a glance

  • Drugs Davunetide (Primary)
  • Indications Alzheimer's disease; Schizophrenia
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Allon Therapeutics
  • Most Recent Events

    • 15 Mar 2010 New trial record
    • 11 Mar 2010 Results reported in an Allon Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top